We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Merck Millipore Announces Exclusive Agreement with Julphar Diabetes

News   Aug 08, 2012

 
Merck Millipore Announces Exclusive Agreement with Julphar Diabetes
 
 
 

RELATED ARTICLES

Making Chemotherapy More Effective Against Pancreatic Cancer

News

Using patient cell lines and tumor-bearing models, researchers have discovered that inhibition of GSK-3, an enzyme involved in many cancer-promoting processes, sensitizes pancreatic cancer cell lines to gemcitabine, the most commonly used chemotherapy.

READ MORE

Researchers Use CRISPR to Correct Mutation in Duchenne Muscular Dystrophy Model

News

Researchers at the University of Missouri School of Medicine have shown in a mouse study that the powerful gene editing technique known as CRISPR may provide the means for lifelong correction of the genetic mutation responsible for Duchenne muscular dystrophy.

READ MORE

$27 Million Grant Focuses on the Future of Biomanufacturing

News

A new 5-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE